Børge Nordestgaard

Medicine & Life Sciences

1. Population 100%
2. Random Allocation 77%
3. Myocardial Ischemia 62%
4. Chronic Obstructive Pulmonary Disease 61%
5. Cardiovascular Diseases 54%
6. Breast Neoplasms 51%
7. Genotype 49%
8. Myocardial Infarction 48%
9. LDL Cholesterol 46%
10. Lipoprotein(a) 43%
11. Confidence Intervals 43%
12. Meta-Analysis 40%
13. Genome-Wide Association Study 40%
14. Single Nucleotide Polymorphism 39%
15. C-Reactive Protein 39%
16. Alleles 36%
17. Cholesterol 36%
18. Triglycerides 35%
19. Odds Ratio 34%
20. Prostatic Neoplasms 32%
21. Mortality 32%
22. Heterozygote 31%
23. Mendelian Randomization Analysis 30%
24. Cohort Studies 29%
25. Heart 29%
26. HDL Cholesterol 28%
27. Prospective Studies 26%
28. Stroke 25%
29. Genetic Variation 24%
30. Telomere 23%
31. Lipids 23%
32. Hydroxymethylglutaryl-CoA Reductase Inhibitors 22%
33. Genes 22%
34. Lipoproteins 22%
35. Neoplasms 22%
36. Body Mass Index 21%
37. Lung 20%
38. Smoking 20%
39. Vascular Diseases 20%
40. Smokers 19%
41. Coronary Disease 19%
42. Homozygote 18%
43. Hyperlipoproteinemia Type II 18%
44. Type 2 Diabetes Mellitus 18%
45. Mutation 18%
46. Venous Thromboembolism 18%
47. Atherosclerosis 17%
48. Estrogen Receptors 17%
49. Asthma 17%
50. 25-hydroxyvitamin D 16%